alovudine has been researched along with 16-fluoroestradiol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vallabhajosula, S | 1 |
Aboagye, EO; Al-Nahhas, A; Kenny, LM | 1 |
Cintolo, JA; Pryma, DA; Tchou, J | 1 |
2 review(s) available for alovudine and 16-fluoroestradiol
Article | Year |
---|---|
(18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Topics: Amino Acids; Animals; Bone and Bones; Cell Hypoxia; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Estradiol; Fluorine Radioisotopes; Fluoroacetates; Fluorodeoxyglucose F18; Glucose; Humans; Membrane Lipids; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response.
Topics: Breast Neoplasms; Clinical Trials as Topic; Dideoxynucleosides; Early Detection of Cancer; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2013 |
1 other study(ies) available for alovudine and 16-fluoroestradiol
Article | Year |
---|---|
Novel PET biomarkers for breast cancer imaging.
Topics: Biomarkers, Tumor; Breast Neoplasms; Dideoxynucleosides; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Methionine; Positron-Emission Tomography | 2011 |